V015-2121 Screening compound: 1-[1-(4-chlorophenyl)cyclopentanecarbonyl]-4-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}piperidine

V015-2121 Screening compound: 1-[1-(4-chlorophenyl)cyclopentanecarbonyl]-4-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}piperidine
V015-2121 Screening compound: 1-[1-(4-chlorophenyl)cyclopentanecarbonyl]-4-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}piperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-2121
1-[1-(4-chlorophenyl)cyclopentanecarbonyl]-4-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}piperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-2121

Molecular Formula

C26H25ClF3N3O2 (C26 H25 ClF3 N3 O2)

Compound Name

1-[1-(4-chlorophenyl)cyclopentanecarbonyl]-4-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}piperidine

IUPAC name

1-[1-(4-chlorophenyl)cyclopentanecarbonyl]-4-{3-[4-(trifluoromethyl)phenyl]-124-oxadiazol-5-yl}piperidine

SMILES

O=C(C1(CCCC1)c(cc1)ccc1Cl)N(CC1)CCC1c1nc(-c2ccc(C(F)(F)F)cc2)no1

InChI

InChI=1S/C26H25ClF3N3O2/c27-21-9-7-19(8-10-21)25(13-1-2-14-25)24(34)33-15-11-18(12-16-33)23-31-22(32-35-23)17-3-5-20(6-4-17)26(28,29)30/h3-10,18H,1-2,11-16H2

InChI Key

MMKSJOCMAMDXCJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19958743

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

503.95

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.958

Distribution Coefficient, logD

6.958

Water Solubility, LogSw

-6.70

Polar Surface Area

48.579

Acid Dissociation Constant (pKa)

24.75

Base Dissociation Constant (pKb)

-0.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.30

V015-2121 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V015-2121 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-2121?
Check Price and Availability of V015-2121, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-2121 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-2121
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-2121
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-2121 available by request